Delivery Order 36F79722D0197-36C26224F0036
- This is a firm fixed price delivery order awarded to Telix Pharmaceuticals US Inc. by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) with a ceiling value of $165,000.00. The contract is for the supply of Telix's radiopharmaceutical products, including Illuccix for prostate cancer imaging and Gozetotide for other nuclear medicine procedures, to VA medical facilities across the country. This award is part of Telix's broader contract vehicles with the VA, which include...
- This is a federal contract award to Telix Pharmaceuticals US Inc., a global biopharmaceutical company, by the U.S. Department of Veterans Affairs (VA) through its Veterans Health Administration (VHA). The contract, with a ceiling value of $858,000.00, is for the delivery of various radiopharmaceuticals to support the VA's nuclear medicine and medical imaging services for veterans. The contract is a Blanket Purchase Agreement (BPA) call order awarded under a larger $17.5 million BPA the company...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Telix Pharmaceuticals US Inc., a for-profit manufacturer of goods. The $161,700 contract is for the supply of Telix's radiopharmaceutical products, including Illuccix for prostate cancer imaging and Gozetotide for other nuclear medicine procedures, to VA medical facilities through February 2025. This award is part of a larger $17.5 million Blanket Purchase Agreement (BPA) the VA awarded Telix in...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Telix Pharmaceuticals US Inc., a global commercial-stage biopharmaceutical company that manufactures diagnostic and therapeutic radiopharmaceutical products. The $774,700.00 call order is for the supply of various radiopharmaceuticals, including Illuccix for prostate cancer imaging and Gozetotide for other nuclear medicine procedures,...
- Telix Pharmaceuticals US Inc. has been awarded a $479,500 firm fixed price delivery order against a Blanket Purchase Agreement to provide radiopharmaceutical Illuccix for prostate cancer imaging services. The order was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 located in Dublin, Ohio, with a completion date of November 6, 2023. As a manufacturer of radiopharmaceutical goods, Telix Pharmaceuticals supports nuclear medicine...
- This federal contract award was made by the U.S. Department of Veterans Affairs (VA) to Telix Pharmaceuticals US Inc., a global biopharmaceutical company specializing in radiopharmaceutical products for nuclear medicine and medical imaging. The $1,750,000.00 contract is a Blanket Purchase Agreement (BPA) call order for the supply of the radiopharmaceutical product Illuccix, which is used for prostate cancer imaging. The contract has a firm fixed price pricing type and a performance period ending...
- This is a firm fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Telix Pharmaceuticals US Inc. The contract has a ceiling value of $432,300.00 and an ultimate completion date of February 11, 2026. It is for the supply of ILLUCCIX PSMA VASD, a radiopharmaceutical product used for nuclear medicine and medical imaging services. The contract is not set aside and is part of Telix Pharmaceuticals' existing Federal Supply Schedule (FSS) contracts under...
- This is a federal contract award to Telix Pharmaceuticals US Inc., a global biopharmaceutical company, by the U.S. Department of Veterans Affairs (VA). The contract, valued at $1,815,000.00, is a Blanket Purchase Agreement (BPA) call order for the radiopharmaceutical product Illuccix. Illuccix is used for nuclear medicine and medical imaging services, with a focus on oncology applications. The contract has an ultimate completion date of September 30, 2025 and is a firm fixed-price arrangement....
- <p>The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 (VA - VHA) awarded a $665,200 firm fixed price delivery order contract to Telix Pharmaceuticals US Inc. to provide ILLUCCIX (MEDICATION) ORDER. The contract has a period of performance from July 11, 2022 through October 31, 2022 and will be performed at the VETERANS ADMINISTRATION facility located in West Los Angeles, California.</p>
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 (VA - VHA) awarded a $385,000 Delivery Order contract to Telix Pharmaceuticals US Inc. to provide Emergency ILLUCCIX (Nuclear Medicine) for the VA San Diego Healthcare System located in San Diego, California. The firm fixed price contract runs from July 19, 2022 through June 9, 2023 and tasks the prime contractor, Telix Pharmaceuticals US Inc., with supplying nuclear medicine products to...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79722D0197Federal Supply Schedule
- 36F79722D0197-36C26224F0036Delivery Order
This is a firm fixed price delivery order awarded to Telix Pharmaceuticals US Inc. by the Department of Veterans Affairs (VA) in the amount of $334,300.00. The award is for the delivery of Illuccix, a radiopharmaceutical used for prostate cancer imaging, to support the VA's nuclear medicine and medical imaging services. The award was issued under Telix's existing $17.5 million Blanket Purchase Agreement (BPA) with the VA National Acquisition Center, as well as the company's other contract vehicles with the VA Federal Supply Schedule. These contracting mechanisms enable the VA to efficiently procure Telix's radiopharmaceutical products to fulfill the imaging and nuclear medicine requirements of its healthcare system serving veterans. The award has an ultimate completion date of October 31, 2024 and does not include any small business set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Supplemental Agreement for work within scope | ($9k) | 1/24/25 | |
| P00002 | Supplemental Agreement for work within scope | ($147k) | 8/14/24 | |
| P00001 | Supplemental Agreement for work within scope | $273.0k | 4/18/24 | |
| Not listed | Not listed | $217.0k | 10/10/23 |